newscientist.com

Should we use GLP-1 drugs to treat obesity in children? | New Scientist

Children as young as 8 in the US are being prescribed off-label GLP-1 weight-loss drugs, sparking debate about the potential long-term health effects

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.